Jody Vance, well-known Vancouver-based talk show personality talks with Jeremy Sobotta, Perimeter Medical Imaging (PINK.C) CEO, to get a good look at the company’s mandate of improving the effectiveness…
Health Science
Stock Performance Perimeter’s mission is to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address unmet medical needs. The operators have a vision that patients will no…
Data protection Earlier this week a federal review echoed The Canadian Ministry of Health’s original decision to deny data protection for Johnson & Johnson (JNJ.Q)’s Spravato product, a ketamine-derived…
Medexus Pharmaceuticals (MDP.T) announced today that it has completed enrollment in its Phase 4 clinical trial of IXINITY®, targeting label expansion for pediatric hemophilia B. We are hopeful that…
Nova Mentis Life Science (NOVA.C) announced it has filed for orphan drug designation with the European Medicines Agency (EMA) for its propriety psilocybin drug to help treat patients with fragile…
Xeris Pharmaceuticals (XERS.Q) announces today that the U.S. Food and Drug Administration (FDA) has allowed the Investigational New Drug Application (IND) for the Company’s XeriSol™ levothyroxine (XP-8121) for hypothyroidism…
Sixth Wave Innovations (SIXW.C) signed an amendment to the research agreement and grant sponsored by the Natural Sciences and Engineering Research Council of Canada (NSERC). The grant and research…
Stock Performance From the chart below it seemed like the Valeo Pharma (“VPH”) shareholders have had quite a wild ride over the last few years. Starting in 2019 the…
I am writing about Valeo Pharma Inc. at a very fascinating time for biotech/health stocks. Recently, Biotech has been hot! Led by the vaccine companies which are soaring. Just…
Steve Saviuk, president and CEO of Valeo Pharma (VPH.C), talks about the transformative partnerships with international players such as Novartis and members of the Canadian Healthcare Industry, that allow…